Last reviewed · How we verify
adjuvant chemotherapy with 5-FU associated with oxaliplatin
adjuvant chemotherapy with 5-FU associated with oxaliplatin is a Small molecule drug developed by University of Sao Paulo General Hospital. It is currently in Phase 1 development.
At a glance
| Generic name | adjuvant chemotherapy with 5-FU associated with oxaliplatin |
|---|---|
| Sponsor | University of Sao Paulo General Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Impact of Adjuvant Chemotherapy in Patients With Colon Cancer (NA)
- ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- adjuvant chemotherapy with 5-FU associated with oxaliplatin CI brief — competitive landscape report
- adjuvant chemotherapy with 5-FU associated with oxaliplatin updates RSS · CI watch RSS
- University of Sao Paulo General Hospital portfolio CI
Frequently asked questions about adjuvant chemotherapy with 5-FU associated with oxaliplatin
What is adjuvant chemotherapy with 5-FU associated with oxaliplatin?
adjuvant chemotherapy with 5-FU associated with oxaliplatin is a Small molecule drug developed by University of Sao Paulo General Hospital.
Who makes adjuvant chemotherapy with 5-FU associated with oxaliplatin?
adjuvant chemotherapy with 5-FU associated with oxaliplatin is developed by University of Sao Paulo General Hospital (see full University of Sao Paulo General Hospital pipeline at /company/university-of-sao-paulo-general-hospital).
What development phase is adjuvant chemotherapy with 5-FU associated with oxaliplatin in?
adjuvant chemotherapy with 5-FU associated with oxaliplatin is in Phase 1.